Lilly once-weekly diabetes drug proves superior in late-stage trialsBy Bill Berkrot (Reuters) - A once-weekly drug for type 2 diabetes developed by Eli Lilly and Co worked better at controlling blood sugar than three other widely used medicines, according to data from late- stage clinical trials. The data, presented on Saturday at the American Diabetes Association (ADA) meeting in Chicago, also showed that the Lilly shot helped patients lose twice as much weight as those taking Merck & Co's $4 billion-a-year drug, Januvia. ...
Source: Lilly once-weekly diabetes drug proves superior in late-stage trials (http://news.yahoo.com/lilly-once-weekly-diabetes-drug-proves-superior-stage-150601939.html)